{"nct_id":"NCT00500058","title":"A Phase I, Dose-Escalation Study to Assess the Safety and Biological Activity of Recombinant Human Interleukin-18","status":"COMPLETED","status_verified_date":"2017-07","start_date":"2007-07-31","start_date_type":"ACTUAL","primary_completion_date":"2010-03-04","primary_completion_date_type":"ACTUAL","completion_date":"2010-03-04","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["GSK"]}